Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 National Cancer Institute designates Penn's Abramson Cancer Center as 'exceptional'
2 BryoLogyx Announces Cooperative Research and Development Agreement for Bryostatin-1 With National Cancer Institute
3 Immune-Onc Therapeutics Awarded $2.14 Million National Cancer Institute SBIR Grant to Support Development of IO-202, a First-in-Class Antibody Targeting LILRB4
4 National Cancer Institute renews designation of HCI as Comprehensive Cancer Center
5 Huntsman Cancer Institute renewal of designation from the National Cancer Institute
6 Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO® (selinexor) Research
7 Huntsman Cancer Institute receives renewal of designation, $29 million over seven years
8 NCI gives 'exceptional' rating to Penn's Abramson Cancer Center
9 Yale Cancer Center Receives NCI Grant Renewal to Fund Clinical Trials
10 Scientists accelerate progress in preventing drug resistance in lung and pancreas cancers
11 Siteman named among top U.S. cancer centers by U.S. News & World Report
12 NCI-Designated Cancer Centers
13 Huntsman Cancer Institute illuminates potential new treatment in acute myeloid leukemia
14 Digital Health: Enabling the post-COVID-19 transition in cancer care
15 NCI Grants Help Cancer Care Centers Study Telehealth Effectiveness
16 Baylor College Received NCI's Specialized Programs of Research Excellence (SPORE) Grant Funding.
17 Huntsman Cancer Institute Announces Next Major Expansion
18 Chasing Cancer
19 Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic
20 Largest-Ever Study of Prostate Cancer Genomics in Black Men IDs Potential Targets for Precision Therapies
21 Clinical trial tests oral cancer drug to combat respiratory symptoms of COVID-19
22 NCI Studying New Mesothelioma Immunotherapy Combination
23 NCI funds study of telemedicine capacity for rural cancer patients amid COVID-19 pandemic
24 UB professor awarded $1.8 million grant to improve targeted therapies against solid tumors
25 Supporting the Cancer Research Workforce
26 Jupiter Medical Center Acquires Leading-Edge Equipment for Cancer Institute: SF STAT!
27 Adding Celecoxib to FOLFOX Does Not Demonstrate DFS Benefit in Colon Cancer
28 Siteman Cancer Center named among top U.S. cancer centers
29 Improving Apps to Help Cancer Patients Quit Smoking
30 Riney Foundation gives $7.8 million to Winship for multiple myeloma research
31 10 Things to Know About HPV and Throat Cancer
32 Citius Submits Mino-Wrap Briefing Package to FDA for Pre-IND Consult
33 Chemist searches fungi for anticancer drug leads
34 People 'afraid to go to doctors': A third of Americans miss cancer screenings, survey suggests
35 Ignoring cancer now may trade one health crisis for another: NCI chief
36 Frederick National Laboratory for Cancer Research
37 Chembio Investors: Class Action Lawsuit Filed To Recover Investment Losses
38 Study Suggests a Radiomic Model Can Identify High-Risk, Early-Stage Lung Cancer on CT Screening
39 Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
40 Cancer research booms, cancer mortality declines, NCI director says
41 Testing with combined biopsy method improves prostate cancer diagnosis in NIH study
42 XPose Therapeutics embarks on the discovery and development of novel oncology medicines targeting DNA Damage Response with non-dilutive funding from NCI
43 'Tantalyzing solutions': How we are developing the next-generation of cancer drugs
44 PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product
45 Annual Plan and Budget Proposal FY2021
46 Trump's 2021 Budget Plan Slashes Cancer Funding—Again
47 UArizona Health Sciences researcher seeks safer, more effective leukemia treatment
48 AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NIH study
49 In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1
50 Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
51 Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response
52 COVID-19 could slow progress in reducing cancer death, NCI head warns
53 Breast Imaging Market Size to Expand at Highest Revenue US$ 7287.1 Million with Growth Rate at 9.9% CAGR by 2026 | Finds, Coherent Market Insights |
54 Egypt's cancer institute discovers 17 COVID-19 infections among staff
55 With $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR
56 NIH scientists develop blood test to help improve liver cancer screening
57 PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer
58 Open access takes root at National Cancer Institute
59 Elicio Therapeutics and National Cancer Institute Collaborate to Study ELI-002 Mutant KRAS Targeting Mechanism
60 PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute
61 NCI Exceptional Responders Initiative Pilot Study Meets Feasibility Goal
62 NCI Trials for June 2020
63 Annual Report to the Nation: Cancer death rates continue to decline
64 NIH study provides genetic insights into osteosarcoma in children
65 Cell Expansion Market Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2027
66 Study quantifies impact of NCI-sponsored trials on clinical cancer care
67 Higher daily step count linked with lower all-cause mortality
68 AACI Supports NIH, NCI Funding Increases in Federal Budget
69 Truvian Sciences' Easy Check COVID-19 IgM/IgG Test Receives FDA Emergency Use Authorization
70 Personalized Cancer Drugs Market Analysis Trends and Dynamic Demand by Forecast 2017 to 2025
71 The Leukemia & Lymphoma Society Today Announces a Collaboration with the National Cancer Institute and Children's Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
72 Progress being made on National Cancer Institute effort at UAMS
73 An Assessment of Health‐related Quality of Life Endpoints Reporting in Trials Supported by the National Cancer Institute
74 Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
75 NCI Trials for July 2020
76 UAMS chief: Progress being made on National Cancer Institute effort
77 CROWN Consortium Receives $5M from National Cancer Institute to Advance Cancer Research across 48 Counties in Wisconsin and Northern Michigan
78 More Than 10,000 Excess Cancer Deaths due to COVID-19 Delays
79 NCI receives $306 million in new money for COVID-19 serology test research; Details to follow at BSA meeting May 12
80 NCI supports NRG Oncology Biospecimen Bank
81 New Data Repository Could Speed Precision Medicine for Cancer
82 Curadigm announces the selection of its Nanoprimer technology by the National Cancer Institute for a characterization & development collaboration
83 Lantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments
84 A National Cancer Institute Study for HPV-related Head and Neck Cancer Opens at Atlantic Health System
85 Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG(TM) Test
86 Surgical Innovation Associates' Recent Series A Supercharged with $2M Grant from US National Cancer Institute (NCI)
87 BioMarker Strategies Awarded Phase II National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer
88 NCI's Sharpless: COVID-19 Could Halt Streak of US Cancer Mortality Gains
89 AppliedVR and the National Cancer Institute Collaborate to Evaluate Virtual Reality as a Solution to Help Address Cancer-Related Anxiety
90 NCI grant to help patients navigate costs of cancer care
91 Trump tries again to reduce NIH budget, spares FDA from cuts
92 Envisagenics wins another SBIR grant from the National Cancer Institute to enhance their AI/ML platform for Immunotherapy development
93 Sylvester Comprehensive Cancer Center earns prestigious National Cancer Institute designation
94 Immunotherapy drug improves outcomes for some children with relapsed leukemia
95 How COVID-19 broke out at the National Cancer Institute
96 Black cancer patients better represented in publicly-funded clinical trials
97 Listen: Chris Kinsinger, Proteomics Program Director, National Cancer Institute
98 First Two Patients Enrolled in National Cancer Institute Trial of the Ability of Lixte Biotechnology's LB-100 to Enter Recurrent Malignant Brain Tumors
99 Siteman Cancer Center earns highest federal rating – Washington University School of Medicine in St. Louis
100 National Cancer Institute sends more support to Helen F. Graham Cancer Center for research